These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 15223306

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Functionally important amino acid residues in the transient receptor potential vanilloid 1 (TRPV1) ion channel--an overview of the current mutational data.
    Winter Z, Buhala A, Ötvös F, Jósvay K, Vizler C, Dombi G, Szakonyi G, Oláh Z.
    Mol Pain; 2013 Jun 22; 9():30. PubMed ID: 23800232
    [Abstract] [Full Text] [Related]

  • 43. Activation of the cGMP/Protein Kinase G Pathway by Nitric Oxide Can Decrease TRPV1 Activity in Cultured Rat Dorsal Root Ganglion Neurons.
    Jin Y, Kim J, Kwak J.
    Korean J Physiol Pharmacol; 2012 Jun 22; 16(3):211-7. PubMed ID: 22802704
    [Abstract] [Full Text] [Related]

  • 44. Differential role of the menthol-binding residue Y745 in the antagonism of thermally gated TRPM8 channels.
    Malkia A, Pertusa M, Fernández-Ballester G, Ferrer-Montiel A, Viana F.
    Mol Pain; 2009 Nov 03; 5():62. PubMed ID: 19886999
    [Abstract] [Full Text] [Related]

  • 45. Bidirectional shifts of TRPM8 channel gating by temperature and chemical agents modulate the cold sensitivity of mammalian thermoreceptors.
    Mälkiä A, Madrid R, Meseguer V, de la Peña E, Valero M, Belmonte C, Viana F.
    J Physiol; 2007 May 15; 581(Pt 1):155-74. PubMed ID: 17317754
    [Abstract] [Full Text] [Related]

  • 46. Cu2+ (1,10 phenanthroline)3 is an open-channel blocker of the human skeletal muscle sodium channel.
    Popa MO, Lerche H.
    Br J Pharmacol; 2006 Apr 15; 147(7):808-14. PubMed ID: 16432503
    [Abstract] [Full Text] [Related]

  • 47. No pain, no gain: the useful function of angina.
    Bolli R, Abdel-Latif A.
    Circulation; 2005 Dec 06; 112(23):3541-3. PubMed ID: 16330693
    [No Abstract] [Full Text] [Related]

  • 48. Oxidizing reagent copper-o-phenanthroline is an open channel blocker of the vanilloid receptor TRPV1.
    Tousova K, Susankova K, Teisinger J, Vyklicky L, Vlachova V.
    Neuropharmacology; 2004 Aug 06; 47(2):273-85. PubMed ID: 15223306
    [Abstract] [Full Text] [Related]

  • 49. Thimerosal decreases TRPV1 activity by oxidation of extracellular sulfhydryl residues.
    Jin Y, Kim DK, Khil LY, Oh U, Kim J, Kwak J.
    Neurosci Lett; 2004 Oct 21; 369(3):250-5. PubMed ID: 15464274
    [Abstract] [Full Text] [Related]

  • 50. Vanilloid receptor TRPV1 is not activated by vanilloids applied intracellularly.
    Vyklický L, Lyfenko A, Kuffler DP, Vlachová V.
    Neuroreport; 2003 May 23; 14(7):1061-5. PubMed ID: 12802203
    [Abstract] [Full Text] [Related]

  • 51. Reducing and oxidizing agents sensitize heat-activated vanilloid receptor (TRPV1) current.
    Susankova K, Tousova K, Vyklicky L, Teisinger J, Vlachova V.
    Mol Pharmacol; 2006 Jul 23; 70(1):383-94. PubMed ID: 16614139
    [Abstract] [Full Text] [Related]

  • 52. TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia.
    Holzer P.
    Eur J Pharmacol; 2004 Oct 01; 500(1-3):231-41. PubMed ID: 15464036
    [Abstract] [Full Text] [Related]

  • 53. Oxidizing reagent copper-o-phenanthroline is an open channel blocker of the vanilloid receptor TRPV1.
    Tousova K, Susankova K, Teisinger J, Vyklicky L, Vlachova V.
    Neuropharmacology; 2004 Aug 01; 47(2):273-85. PubMed ID: 15223306
    [Abstract] [Full Text] [Related]

  • 54. Thimerosal decreases TRPV1 activity by oxidation of extracellular sulfhydryl residues.
    Jin Y, Kim DK, Khil LY, Oh U, Kim J, Kwak J.
    Neurosci Lett; 2004 Oct 21; 369(3):250-5. PubMed ID: 15464274
    [Abstract] [Full Text] [Related]

  • 55. Vanilloid receptor TRPV1 is not activated by vanilloids applied intracellularly.
    Vyklický L, Lyfenko A, Kuffler DP, Vlachová V.
    Neuroreport; 2003 May 23; 14(7):1061-5. PubMed ID: 12802203
    [Abstract] [Full Text] [Related]

  • 56. Reducing and oxidizing agents sensitize heat-activated vanilloid receptor (TRPV1) current.
    Susankova K, Tousova K, Vyklicky L, Teisinger J, Vlachova V.
    Mol Pharmacol; 2006 Jul 23; 70(1):383-94. PubMed ID: 16614139
    [Abstract] [Full Text] [Related]

  • 57. Block of native and cloned vanilloid receptor 1 (TRPV1) by aminoglycoside antibiotics.
    Raisinghani M, Premkumar LS.
    Pain; 2005 Jan 23; 113(1-2):123-33. PubMed ID: 15621372
    [Abstract] [Full Text] [Related]

  • 58. Oxidizing reagent copper-o-phenanthroline is an open channel blocker of the vanilloid receptor TRPV1.
    Tousova K, Susankova K, Teisinger J, Vyklicky L, Vlachova V.
    Neuropharmacology; 2004 Aug 23; 47(2):273-85. PubMed ID: 15223306
    [Abstract] [Full Text] [Related]

  • 59. TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia.
    Holzer P.
    Eur J Pharmacol; 2004 Oct 01; 500(1-3):231-41. PubMed ID: 15464036
    [Abstract] [Full Text] [Related]

  • 60. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007 Oct 01; 26 Suppl 1():3-106. PubMed ID: 17365137
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.